 Danielle Loeb
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physicians, Primary Care | 6 | 2019 | 225 | 1.780 |
Why?
| | Primary Health Care | 10 | 2022 | 1756 | 1.570 |
Why?
| | Mental Disorders | 5 | 2019 | 1123 | 1.420 |
Why?
| | Patient Care Team | 5 | 2019 | 664 | 1.380 |
Why?
| | Attitude of Health Personnel | 4 | 2017 | 1175 | 1.040 |
Why?
| | Self Efficacy | 3 | 2019 | 404 | 0.930 |
Why?
| | Mental Health Services | 3 | 2019 | 445 | 0.920 |
Why?
| | Antidepressive Agents | 2 | 2017 | 243 | 0.800 |
Why?
| | Medical History Taking | 2 | 2011 | 117 | 0.660 |
Why?
| | Chronic Disease | 4 | 2019 | 1811 | 0.650 |
Why?
| | Pharmacy Service, Hospital | 2 | 2019 | 84 | 0.650 |
Why?
| | Internal Medicine | 2 | 2014 | 273 | 0.620 |
Why?
| | Depression | 4 | 2019 | 1487 | 0.580 |
Why?
| | Stakeholder Participation | 1 | 2019 | 81 | 0.580 |
Why?
| | Health Plan Implementation | 1 | 2019 | 142 | 0.570 |
Why?
| | General Practice | 1 | 2016 | 30 | 0.500 |
Why?
| | Sexual Behavior | 2 | 2011 | 493 | 0.500 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 861 | 0.410 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 580 | 0.410 |
Why?
| | Estradiol | 3 | 2025 | 523 | 0.400 |
Why?
| | Comorbidity | 2 | 2015 | 1658 | 0.390 |
Why?
| | Quality Improvement | 2 | 2019 | 1234 | 0.390 |
Why?
| | Perception | 2 | 2015 | 375 | 0.390 |
Why?
| | Psychometrics | 1 | 2016 | 734 | 0.380 |
Why?
| | Disease Management | 1 | 2016 | 628 | 0.380 |
Why?
| | Transgender Persons | 3 | 2025 | 200 | 0.370 |
Why?
| | Surveys and Questionnaires | 6 | 2019 | 5931 | 0.370 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 246 | 0.370 |
Why?
| | Communication | 1 | 2017 | 948 | 0.350 |
Why?
| | Psychotherapy | 1 | 2012 | 184 | 0.340 |
Why?
| | Internship and Residency | 2 | 2011 | 1222 | 0.320 |
Why?
| | Adult | 14 | 2025 | 39134 | 0.310 |
Why?
| | Depressive Disorder | 1 | 2012 | 374 | 0.300 |
Why?
| | Documentation | 1 | 2011 | 193 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1395 | 0.290 |
Why?
| | Telemedicine | 1 | 2017 | 886 | 0.290 |
Why?
| | Electronic Health Records | 2 | 2018 | 1125 | 0.260 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 263 | 0.260 |
Why?
| | Physicians | 2 | 2016 | 928 | 0.250 |
Why?
| | Middle Aged | 13 | 2025 | 34487 | 0.250 |
Why?
| | Focus Groups | 2 | 2019 | 567 | 0.250 |
Why?
| | Ambulatory Care | 1 | 2011 | 584 | 0.250 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5645 | 0.250 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2025 | 270 | 0.250 |
Why?
| | Male | 18 | 2025 | 69893 | 0.240 |
Why?
| | Ergonomics | 1 | 2025 | 24 | 0.240 |
Why?
| | Interviews as Topic | 3 | 2025 | 841 | 0.230 |
Why?
| | Pharmacists | 2 | 2019 | 255 | 0.230 |
Why?
| | Female | 17 | 2025 | 75540 | 0.220 |
Why?
| | Testosterone | 2 | 2025 | 404 | 0.210 |
Why?
| | Humans | 24 | 2025 | 140898 | 0.210 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1328 | 0.200 |
Why?
| | Simulation Training | 1 | 2025 | 126 | 0.200 |
Why?
| | Colorado | 3 | 2019 | 4597 | 0.200 |
Why?
| | Developing Countries | 1 | 2025 | 307 | 0.200 |
Why?
| | Mentoring | 1 | 2025 | 153 | 0.190 |
Why?
| | Guideline Adherence | 2 | 2025 | 553 | 0.180 |
Why?
| | Patient Safety | 1 | 2025 | 334 | 0.180 |
Why?
| | Retrospective Studies | 8 | 2025 | 16315 | 0.180 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 328 | 0.180 |
Why?
| | Hypertension | 3 | 2022 | 1251 | 0.170 |
Why?
| | Heart Arrest | 1 | 2025 | 384 | 0.170 |
Why?
| | Patient Preference | 1 | 2022 | 203 | 0.160 |
Why?
| | Southwestern United States | 1 | 2019 | 94 | 0.160 |
Why?
| | Urban Health Services | 1 | 2019 | 68 | 0.150 |
Why?
| | Qualitative Research | 2 | 2016 | 1525 | 0.140 |
Why?
| | Logistic Models | 2 | 2014 | 2088 | 0.140 |
Why?
| | Program Development | 1 | 2018 | 364 | 0.120 |
Why?
| | Health Personnel | 2 | 2019 | 724 | 0.120 |
Why?
| | Injections, Subcutaneous | 2 | 2025 | 165 | 0.110 |
Why?
| | Benzodiazepines | 1 | 2016 | 162 | 0.110 |
Why?
| | Injections, Intramuscular | 2 | 2025 | 135 | 0.110 |
Why?
| | Prevalence | 1 | 2022 | 2780 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2019 | 794 | 0.100 |
Why?
| | Aged | 6 | 2017 | 24666 | 0.100 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 44 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 304 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 645 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 536 | 0.080 |
Why?
| | Professional-Patient Relations | 1 | 2012 | 151 | 0.080 |
Why?
| | Adolescent | 5 | 2025 | 22027 | 0.080 |
Why?
| | Dietary Fats | 1 | 2012 | 299 | 0.080 |
Why?
| | Registries | 1 | 2018 | 2143 | 0.080 |
Why?
| | Sexually Transmitted Diseases | 1 | 2011 | 165 | 0.070 |
Why?
| | Anxiety | 1 | 2016 | 1076 | 0.070 |
Why?
| | Lymphoma, T-Cell | 1 | 2009 | 29 | 0.070 |
Why?
| | Intestinal Neoplasms | 1 | 2009 | 31 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3336 | 0.070 |
Why?
| | Counseling | 1 | 2012 | 395 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2524 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2010 | 527 | 0.070 |
Why?
| | United States | 4 | 2025 | 15195 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 702 | 0.060 |
Why?
| | Healthcare Failure Mode and Effect Analysis | 1 | 2025 | 1 | 0.060 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 467 | 0.060 |
Why?
| | Workflow | 1 | 2025 | 175 | 0.050 |
Why?
| | Virtual Reality | 1 | 2025 | 74 | 0.050 |
Why?
| | Curriculum | 1 | 2010 | 1029 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 9 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2025 | 609 | 0.050 |
Why?
| | Young Adult | 2 | 2025 | 13646 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2025 | 532 | 0.040 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 213 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2012 | 7899 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2082 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2093 | 0.040 |
Why?
| | Pharmacies | 1 | 2019 | 39 | 0.040 |
Why?
| | Behavior | 1 | 2019 | 92 | 0.040 |
Why?
| | Pharmaceutical Services | 1 | 2019 | 83 | 0.040 |
Why?
| | Medication Therapy Management | 1 | 2019 | 78 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 587 | 0.030 |
Why?
| | Professional Role | 1 | 2019 | 164 | 0.030 |
Why?
| | Models, Organizational | 1 | 2018 | 143 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 59 | 0.030 |
Why?
| | Child | 2 | 2025 | 22313 | 0.030 |
Why?
| | Chronic Pain | 1 | 2019 | 278 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 152 | 0.020 |
Why?
| | Infant | 1 | 2025 | 9790 | 0.020 |
Why?
| | Health Expenditures | 1 | 2012 | 193 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11462 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 562 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3000 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5789 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2009 | 307 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 327 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1310 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 414 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2051 | 0.010 |
Why?
| | Antigens, CD | 1 | 2009 | 544 | 0.010 |
Why?
| | Celiac Disease | 1 | 2009 | 295 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1491 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3278 | 0.010 |
Why?
| | Prospective Studies | 1 | 2016 | 7749 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1243 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 10430 | 0.010 |
Why?
|
|
Loeb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|